MedPath

The Effect of Boswellia Serrata Extract on Osteoarthritis

Phase 3
Recruiting
Conditions
Osteoarthritis.
Osteoarthritis of knee
Registration Number
IRCT20190107042264N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patient's presenting with knee pain with Osteoarthritis as a diagnosis
at least three months since diagnosis
Visual Analog Scale score must be more than 40 after stopping the treatment for 7 days
Lequesne functional Index more than 7 after stopping the treatment for 7 days
Patients must have the ability to stand and walk and to provide written and oral consent

Exclusion Criteria

Allergy of any kind to Boswellia and any of it's derivatives
Malignancy
Patient's unresponsive to conventional treatment
Inflammatory Arthropathies
Hyperuricemia
Surgery planned
New injury in sight of OA
Intraarticular corticosteroid injection in the past 3 months
Liver or Renal Failure
History of gastric ulceration
Uncontrolled Hypertension
Congestive Heart Failure
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stiffness of the Joint. Timepoint: The beginning of the study, 7, 14, 28 days after start of drug use. Method of measurement: The Western Ontario and McMaster Universities Osteoarthritis Index.;Joint function. Timepoint: The beginning of the study, 7, 14, 28 days after start of drug use. Method of measurement: The Western Ontario and McMaster Universities Osteoarthritis Index; Lequesne Functional Index.;Pain. Timepoint: The beginning of the study, 7, 14, 28 days after start of drug use. Method of measurement: The Western Ontario and McMaster Universities Osteoarthritis Index; Visual Analog Scale.;Improvement in Quality of Life. Timepoint: The end of the study. Method of measurement: Summation and Analysis of The Western Ontario and McMaster Universities Osteoarthritis Index and Visual Analog Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath